Brief: Corline Biomedical Signs Supplement To Existing License And Delivery Agreement With Kardium
Aug 11 (Reuters) - Corline Biomedical AB CLBIO.ST :
* AGREES WITH KARDIUM ON ADDITIONAL AGREEMENT TO EXISTING
LICENSE
AND DELIVERY AGREEMENT SIGNED IN SEPTEMBER 2020
* KARDIUM NOW COMMITS TO MAKE QUARTERLY PAYMENTS TO CORLINE
CORRESPONDING TO APPROXIMATELY SEK 3.7 MILLION ANNUALLY
* ADDITIONAL AGREEMENT ALSO MEANS THAT KARDIUM WILL TAKE THE
COSTS
OF ANNUAL MAINTENANCE FEE OF $130,000
Source text for Eikon: ID:nGNE5VBfqr
Further company coverage: CLBIO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Corline Biomedical AB
See all newsBrief: Corline Biomedical Expectes Positive EBITDA In 2027
Brief: Corline Biomedical: Canada To Grant Kardium Up To C$31.25 Mln For Manufacturing Capacity Expansion
Brief: Corline Biomedical Q2 Net Sales Amount To SEK 4.7 Million
Brief: Corline Biomedical Partner Kardium Receives Approval For Globe Pulsed Field System In Canada
Brief: Corline Biomedical Q1 Result After Financial Items At SEK -2.5 Mln